These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current good manufacturing practices for PET drug products in the United States. Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213 [No Abstract] [Full Text] [Related]
3. Proposed current good manufacturing practice and supplemental regulations. Korun FD Bull Parenter Drug Assoc; 1976; 30(3):139-42. PubMed ID: 1268432 [No Abstract] [Full Text] [Related]
4. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036 [TBL] [Abstract][Full Text] [Related]
5. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction]. Hippenmeier F Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531 [No Abstract] [Full Text] [Related]
6. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
7. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
8. A summarized discussion of current good manufacturing practice regulations. Allen LV Int J Pharm Compd; 2013; 17(3):210-9. PubMed ID: 24046937 [TBL] [Abstract][Full Text] [Related]
9. Comments on the ADD-vantage system. Robertson C; Schannuth R Am J Hosp Pharm; 1992 Jun; 49(6):1397. PubMed ID: 1529978 [No Abstract] [Full Text] [Related]
10. Comments on the ADD-Vantage system. Boylan JC Am J Hosp Pharm; 1992 Jun; 49(6):1396-7; author reply 1397-8. PubMed ID: 1529977 [No Abstract] [Full Text] [Related]
11. New recommendations to modernize drug manufacturing. FDA Consum; 2007; 41(1):4. PubMed ID: 17354283 [No Abstract] [Full Text] [Related]
12. Disinfectants as an aid for good manufacturing practice in the pharmaceutical industry. Wallhäusser KH J Pharm Belg; 1981; 36(5):283-97. PubMed ID: 7310623 [No Abstract] [Full Text] [Related]
13. [Practical realization of manufacturing control in Switzerland]. Witschi T Pharm Acta Helv; 1972; 47(11):637-47. PubMed ID: 4657533 [No Abstract] [Full Text] [Related]
14. [Round table on the "norms for good drug compounding"]. Boll Chim Farm; 1970 Nov; 109(11):635-52. PubMed ID: 5515584 [No Abstract] [Full Text] [Related]
15. The literature on formulation: its effect on drug product selection. Heller WM Am J Pharm Sci Support Public Health; 1977; 149(4):113-8. PubMed ID: 416721 [No Abstract] [Full Text] [Related]
16. International Conference on Harmonisation; guidance on Q5E Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2005 Jun; 70(125):37861-2. PubMed ID: 15988855 [TBL] [Abstract][Full Text] [Related]
17. Drug information: a basic bibliography--1990. Bell JE Hosp Pharm; 1989 Dec; 24(12):1031-2. PubMed ID: 10304165 [No Abstract] [Full Text] [Related]